期刊文献+

高龄急性冠状动脉综合征非完全血运重建介入治疗临床观察 被引量:5

暂未订购
导出
摘要 目的:探讨高龄急性冠脉综合征非完全血运重建介入治疗的临床疗效。方法:选择年龄〉70岁急性冠状动脉综合征患者,冠脉造影呈多支病变200例(双支病变128例,三支病变72例),对其中146例仅进行"罪犯血管病变"介入治疗,"罪犯血管病变"根据心电图改变及影像学特征进行判断。结果:介入手术即刻成功率为98.0%(144/146),术中发生急性心血管事件1.4%(2/146);术后住院期间症状及并发症:手术成功的144例中,125例不稳定型心绞痛症状消失率84.8%(106/125),明显减轻率15.2%(19/125),支架内血栓形成致急性心肌梗死发生率1.6%(2/125);19例急性心肌梗死中病死率5.3%(1/19);术后随访1~24月,心绞痛症状复发率12.5%(18/143),急性心肌梗死发生率1.3%(2/143),病死率0.7%(1/143),原"罪犯血管"重建率10.4%(15/143),原非"罪犯血管"介入治疗率13.8%(20/143)。结论:高龄急性冠状动脉综合征患者冠状动脉造影显示多支血管病变常见,但导致急性冠状动脉综合征发生的"罪犯血管"多为其中一支,仅处理"罪犯血管"的非完全血运重建介入治疗具有非常良好的临床疗效,只要能正确的判断"罪犯血管",不但能减轻患者及社会的经济负担,同时也有利于提高介入治疗的安全性。
出处 《陕西医学杂志》 CAS 2010年第10期1359-1360,共2页 Shaanxi Medical Journal
  • 相关文献

参考文献2

二级参考文献21

  • 1Park S J, Park SW, Lee J J, et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardio ,2003,91 : 12-16.
  • 2Chieffo A, Stankovie G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation,2005,111:791-795.
  • 3Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long- term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at Rotterdam cardiology hospital registries (RESEARCH and TSEARCH ). Circulation, 2005,111 : 1383-1389.
  • 4Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry ( ACC-NCDR ). Catheter Cardiovasc Interv,2006,68 : 867-872.
  • 5Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg,2006,29:486-491.
  • 6Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines ( ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol,2006,47 :e1-e121.
  • 7Silber S, Albertsson p, Aviles FF, et al.Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J, 2005,26:804-847.
  • 8Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol,2006 ,48 :2584-2591.
  • 9Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J,2006,27: 2784-2814.
  • 10Suero JA, Marso SP, Jones PC, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol, 2001,38: 409-414.

共引文献9

同被引文献26

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部